{"url_path":"/sec/pbsv/8-k/2026-06-15/item-2-02","section_key":"item-2-02","section_title":"Item 2.02 Results of Operations and Financial Condition.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-15","source_url":"https://www.sec.gov/Archives/edgar/data/1304161/0001654954-26-005989-index.html","accession_number":"0001654954-26-005989","cik":"0001304161","ticker":"PBSV","issuer_name":"Pharma-Bio Serv, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1304161/0001654954-26-005989-index.html","primary_entity_key":"0001304161","primary_entity_name":"Pharma-Bio Serv, Inc."},"word_count":130,"has_tables":true,"body_markdown":"**Item 2.02. Results of Operations and Financial Condition.**\n\n \n\nOn June 15, 2026, Pharma-Bio Serv, Inc. (the “Company”) issued a press release announcing its results of operations for the quarter ended April 30, 2026. A copy of the press release is furnished as Exhibit 99.1 to this report.\n\n \n\nThe information furnished pursuant to this Item 2.02, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under that section and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing."}